Delayed molgramostim administration after autologous peripheral blood stem cell transplantation does not add any benefit regarding hematological engraftment and supportive therapy requirements: A prospective randomized trial

Category Primary study
JournalTurkish Journal of Cancer
Year 2006
This article has no abstract
Epistemonikos ID: 616bb31e6ffdca7909f48cabf05a4df322a72bb9
First added on: Feb 04, 2025